SHARES PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic decline today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by more than fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts specula